The MANGUA Project: A Population-Based HIV Cohort in Guatemala
Table 2
Patient characteristics at enrollment in the MANGUA cohort.
(, % of available data from variable)
Total
Men
Women
value
%
%
%
Gender ( = 21 697, 100%)
Age in years ( = 21 629, 99.7%)
<0.0001
Median, IQR
33 (27–42)
16–24
3660
16.8
1616
44.5
2013
55.5
25–49
15079
69.1
9182
61.4
5779
38.6
≥
3073
14.1
2106
68.6
964
18.6
Ethnic group ( = 12 172, 56.1%)
Ladino
9842
80.9
5881
59.8
3961
40.2
0.91
Indigenous
2330
19.1
1395
59.9
935
40.1
Transmission route ( = 12 592, 58%)
<0.0001
Heterosexual
11709
92.5
6593
56.4
5102
43.6
Homosexual
907
7.2
844
98.1
16
1.9
Injection drug users
40
0.3
34
91.9
3
8.1
Advanced HIV at enrollment ( = 10892, 50.2%)
4168
38.3
2778
66.7
1390
33.3
<0.0001
CD4 cells/mL at enrollment ( = 12219, 56.3%)
<0.0001
Median, IQR
131 (46–279)
≥350
2129
17.4
956
44.9
1173
55.1
200–349
2311
18.9
1203
52.1
1108
47.9
<200
7779
63.7
5208
66.9
2571
33.1
cART status at enrollment ( = 8919, 41.1%)
Naive
7981
89.5
4793
60.1
3188
39.9
0.01
Previous treatment
938
10.5
550
58.6
388
41.4
Median (IQR) time in days between HIV diagnosis and cART initiation in days ( = 13195, 60.8%)
75 (27–308)
NA
70 (28–247)
NA
86 (26–388)
NA
0.97
values were calculated taking into account that transexuals () were added to men for statistical convenience. was considered as statistically significant. Clinical stages 3 and 4 from WHO. Not applied. IQR: interquartile range; cART: combination antiretroviral therapy.
